<Disease><Name>HYPERPHENYLALANINEMIA DUE TO 6-PYRUVOYLTETRAHYDROPTERIN SYNTHASE DEFICIENCY (PTPS)</Name><Synonym>PHENYLKETONURIA III; BIOPTERIN SYNTHESIS DEFICIENCY; PKU III; PTPS</Synonym><OMIM><Number>261640</Number><URL>http://omim.org/entry/261640</URL></OMIM><Orphanet><Number>13</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=13</URL></Orphanet><Protein><Number>6-Pyruvoyl tetrahydropterin synthase</Number><URL>http://www.uniprot.org/uniprot/Q03393</URL></Protein><ExPASy><Number>4.2.3.12</Number><URL>http://enzyme.expasy.org/EC/4.2.3.12</URL></ExPASy><Gene>11q22.2-q23.3</Gene><ICD>E70.1</ICD><Summary>rare ;autosomal recessive ;typical and atypical peripheral form ;relatively common in the Arab population [Almannai M 2019];Diagnosis: BH4-Test normalisation of plasma phenylalanine after BH4 load (20 mg/kg bw)</Summary><Symptoms><symtomp><id>2074</id><symptom>Amino acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2363</id><symptom>basal ganglia, changes, lesions, calcifications (MRI, CT)</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1952</id><symptom>behavior, self-mutilating or destructive / behaviour, self-mutilating or destructive</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>4063</id><symptom>decreased hair pigmentation (hypopigmented)</symptom><category>SKIN</category></symtomp><symtomp><id>3982</id><symptom>drooling</symptom><category>HEAD</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1698</id><symptom>fetal akinesia/hypokinesia sequence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1713</id><symptom>fever, severe or recurrent</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2631</id><symptom>hypersalivation</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>2537</id><symptom>hyperthermia</symptom><category>ENDOCRINE SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3381</id><symptom>learning disability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2513</id><symptom>oculogyric crisis</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2089</id><symptom>Organic acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2273</id><symptom>pneumonia</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1919</id><symptom>progressive neurologic defect</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4041</id><symptom>seizures, myoclonic</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3343</id><symptom>skin rash, eczematous or seborrhoic / skin rash</symptom><category>SKIN</category></symtomp><symtomp><id>1700</id><symptom>small for gestational age (SGA), intrauterine growth retardation (IUGR)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2142</id><symptom>swallowing difficulties</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3315</id><symptom>temperature instability</symptom><category>GENERAL TOPICS | GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1624</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>1.80</min><max>12.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1652</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>3.50</min><max>11.20</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1781</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>120.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1837</id><name>Neopterin</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1961</id><name>Phenylalanine</name><specimen>blood</specimen><value>increased</value><min>0.00</min><max>120.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1962</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>34.00</min><max>86.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>2089</id><name>Biopterin</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>2090</id><name>Biopterin</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2140</id><name>Prolactin</name><specimen>serum</specimen><value>increased</value><min>4.79</min><max>23.30</max><unit>ng/ml</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1387</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>910</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>normal/dec</value><min>120.00</min><max>500.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>931</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>normal/dec</value><min>105.00</min><max>299.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1001</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>normal/dec</value><min>    </min><max>11.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1388</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>normal/dec</value><min>0.20</min><max>8.70</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>936</id><name>6-Pyruvoyl tetrahydropterin synthase</name><specimen>erythrocytes</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>937</id><name>6-Pyruvoyl tetrahydropterin synthase</name><specimen>liver</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>424</id><name>Biopterin</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>425</id><name>Biopterin</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>426</id><name>Biopterin</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>934</id><name>Biopterin</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>10.00</min><max>50.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>684</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>685</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>686</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>687</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>688</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2022</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>911</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>100.00</min><max>900.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>932</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>211.00</min><max>871.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1919</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>422</id><name>Neopterin</name><specimen>urine</specimen><value>increased</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1054</id><name>Neopterin</name><specimen>urine</specimen><value>increased</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>423</id><name>Neopterin</name><specimen>urine</specimen><value>increased</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>427</id><name>Neopterin</name><specimen>urine</specimen><value>increased</value><min>0.20</min><max>1.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>935</id><name>Neopterin</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>9.00</min><max>20.00</max><unit>nmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1055</id><name>Neopterin</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>9.00</min><max>40.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>1548</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>156</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>4.00</min><max>32.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>871</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>31.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1513</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>7.00</min><max>28.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>52</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>21.00</min><max>137.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>930</id><name>Phenylalanine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>20.00</max><unit>&#956;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1057</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>35.00</min><max>85.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1294</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>26.00</min><max>85.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1295</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>26.00</min><max>98.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite></Metabolites><Literatures><literature><id>7571</id><title>6-Pyruvoyltetrahydropterin Synthase Deficiency: Review and Report of 28 Arab Subjects</title><author>Almannai M,</author><journal>Pediatr Neurol</journal><year>2019</year><book /><volume>96</volume><number>0</number><pages>40-47</pages><co_aut>et al.</co_aut></literature><literature><id>7574</id><title>Combined Dystonia With Self-Mutilation in 6-Pyruvoyl-Tetrahydropterin Synthase (PTPS) Deficiency: A Case Report</title><author>Latorre A,</author><journal>Mov Disord Clin Pract</journal><year>2018</year><book /><volume>6</volume><number>1</number><pages>81-82</pages><co_aut>et al.</co_aut></literature><literature><id>7575</id><title>Mutational spectrum of PTS gene and in silico pathological assessment of a novel variant in Mexico</title><author>Fernandez-Lainez C,</author><journal>Brain Dev</journal><year>2018</year><book /><volume>40</volume><number>7</number><pages>530-536</pages><co_aut>et al.</co_aut></literature><literature><id>7576</id><title>[PTPS gene analysis and prenatal diagnosis in patients with 6-pyruvoyl-tetra hydropterin synthase deficiency]</title><author>Liu N,</author><journal>Zhonghua Fu Chan Ke Za Zhi</journal><year>2016</year><book /><volume>51</volume><number>12</number><pages>890-894</pages><co_aut>et al.</co_aut></literature><literature><id>7577</id><title>Cost-benefit analysis of hyperphenylalaninemia due to 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency: for consideration</title><author>Lee HH,</author><journal>J Med Screen. 2014 Jun;21(2):61-70. doi: 10</journal><year>2014</year><book /><volume>21</volume><number>2</number><pages>61-70</pages><co_aut>et al.</co_aut></literature><literature><id>7578</id><title>Mutation spectrum of and founder effects affecting the PTS gene in East Asian populations</title><author>Chiu YH,</author><journal>J Hum Genet</journal><year>2012</year><book /><volume>57</volume><number>2</number><pages>145-152</pages><co_aut>et al.</co_aut></literature><literature><id>7572</id><title>Disorders of BH4 metabolism and the treatment of patients with 6-pyruvoyl-tetrahydropterin synthase deficiency in Taiwan</title><author>Niu DM</author><journal>Brain Dev</journal><year>2011</year><book /><volume>33</volume><number>10</number><pages>847-855</pages><co_aut /></literature><literature><id>7573</id><title>Novel mutation affecting the pterin-binding site of PTS gene and review of PTS mutations in Thai patients with 6-pyruvoyltetrah</title><author>Vatanavicharn N,</author><journal>J Inherit Metab Dis Suppl</journal><year>2009</year><book /><volume>32</volume><number>1</number><pages>S279-282</pages><co_aut>et al.</co_aut></literature><literature><id>2783</id><title>LONG-TERM FOLLOW-UP AND OUTCOME OF PATIENTS WITH TETRAHYDROBIPTERIN DEFICIENCY</title><author>Jaeggi L</author><journal>J Inherit Metab Dis Suppl 1</journal><year>2008</year><book /><volume>0</volume><number>0</number><pages>83</pages><co_aut>et al.</co_aut></literature><literature><id>2624</id><title>Long-term outcome and neuroradiological findings of 31 patients with 6-pyruvoyltetrahydropterin synthase deficiency</title><author>Wang L</author><journal>J Inher Met Dis</journal><year>2006</year><book /><volume>29</volume><number>0</number><pages>127-134</pages><co_aut>et al.</co_aut></literature><literature><id>2430</id><title>Critical role of interleukin-1beta for transcriptional regulation of endothelial 6-pyruvoyltetrahydropterin synthase</title><author>Franscini N</author><journal>Arterioscler Thromb Vasc Biol</journal><year>2003</year><book /><volume>23</volume><number>11</number><pages>e50-53</pages><co_aut>et al.</co_aut></literature><literature><id>2429</id><title>Treatment and outcome of Taiwanese patients with 6-pyruvoyltetrahydropterin synthase gene mutations</title><author>Chien YH</author><journal>J Inherit Metab Dis</journal><year>2001</year><book /><volume>24</volume><number>8</number><pages>815-823</pages><co_aut>et al.</co_aut></literature><literature><id>365</id><title>International database of tetrahydrobiopterin deficiencies</title><author>Blau N</author><journal>J Inherit Metab Dis</journal><year>1996</year><book /><volume>19</volume><number>0</number><pages>8-14</pages><co_aut>Barnes I, Dhondt JL</co_aut></literature><literature><id>878</id><title>Retrovirus-mediated gene transfer of 6-pyruvoyl-tetrahydropterin synthase corrects tetrahydrobiopterin deficiency in fibroblasts</title><author>Thony B</author><journal>Hum Gene Ther</journal><year>1996</year><book /><volume>7</volume><number>0</number><pages>1587-1593</pages><co_aut>et al.</co_aut></literature><literature><id>1008</id><title>Hyperphenylalaninemia</title><author>Blau N</author><journal>in Blau N, Duran M, Blaskovics E (eds): in Physicians guide to the laboratory diagnosis of metabolic diseases; Chapman and Hall, London</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>65-78</pages><co_aut>Blaskovics ME</co_aut></literature><literature><id>113</id><title>The hyperphenylalaninemias</title><author>Scriver CR</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1015-1075</pages><co_aut>et al.</co_aut></literature><literature><id>276</id><title>Chromosomal location of two human genes encoding tetrahydrobiopterin-metabolizing enzymes: 6-pyruvoyl-tetrahydropterin synthase </title><author>Thony B</author><journal>Genomics</journal><year>1994</year><book /><volume>19</volume><number>2</number><pages>365-368</pages><co_aut>Heizmann CW, Mattei MG</co_aut></literature><literature><id>277</id><title>Disorders of tetrahydrobiopterin metabolism</title><author>Smith I</author><journal>in Fernandes J, Saudubray J-M, Tada K (eds): Inborm metabolism diseases. Diagnosis and treatment. Berlin, Springer Verlag</journal><year>1991</year><book /><volume>0</volume><number>0</number><pages>183-</pages><co_aut /></literature></Literatures></Disease>